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‘SWEET’ is an acronym standing for ‘Better control in pediatric and
adolescent diabeteS: Working to crEate CEnTers of Reference (CORs)’ and is
based on a partnership of established national and European diabetes
organizations such as International Diabetes Federation, Federation of
European Nurses in Diabetes, and Primary Care Diabetes Europe (PCDE,
www.sweet-project.eu). A three-level classification of centers has been put
forward. In addition to centers for local care, SWEET collaborating centers
on their way to being a COR have been defined. Peer-audited CORs with a
continuous electronic documentation of at least 150 pediatric patients with
diabetes treated by a multidisciplinary team based on the International
Society for Pediatric and Adolescent Diabetes (ISPAD) Clinical Practice
recommendations have been created in 12 European countries. In 2011, they
cared for between 150 to more than 700 youth with diabetes with an average
hemoglobin A1c between 7.6 and 9.2%. Although these clinics should not be
regarded as representative for the whole country, the acknowledgment as
COR includes a common objective of targets and guidelines as well as
recognition of expertise in treatment and education at the center. In a first
step, the SWEET Online platform allows 12 countries using 11 languages to
connect to one unified diabetes database. Aggregate data are de-identified and
exported for longitudinal health and economic data analysis. Through their
network, the CORs wish to obtain political influence on a national and
international level and to facilitate dissemination of new approaches and
techniques. The SWEET project hopes to extend from the initial group of
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In the 1990s, a group of leading pediatric diabetes
centers chose to compare their outcomes by means
of a centralized determination of the most relevant
laboratory value of prognostic importance for the
long-term outcome, the hemoglobin A1c (HbA1c).
This Hvidøre Study Group on Children’s Diabetes
published their first paper in 1997 (1) and showed that
there was great variation in mean HbA1c from 7.4 to
9.1% in 2873 children and adolescents with diabetes
between centers in 21 countries. In the centers where
youth had lower HbA1c they did not necessarily have
higher rates of hypoglycemia. The subsequent Hvidøre
studies have systematically examined why the centers
were so different, but center differences still persisted
(2, 3). To date, all the Hvidøre studies suggest that pos-
itive outcomes are influenced by consistent messages
and philosophies by all team members, good psychoso-
cial support, defined targets, and structured consistent
education to achieve active self-management (4).
Previous research within the ‘Better control in
pediatric and adolescent diabetes: working to create
Centers of Reference (SWEET)’ project regarding
systems for quality control in pediatric diabetes care in
Europe demonstrated that these existed in 9 of the 27
countries (5) and differed widely in their coverage,
the set of indicators collected, and their feedback
to the participants. Probably, the most extensive
system was operating in Germany and Austria; their
Diabetes Patienten Verwaltung, German Electronic
Health Record for Diabetes-Initiative covered up to
80% of all existing pediatric and adolescent patients
[over 27 000 individuals in 2005 (6), collecting and
processing a wide spectrum of data from every diabetic
patient]. Already in 2008 they were able to show that
comparing the time period of 1995–1997 to 2003–2004,
the percentage of pediatric patients within the HbA1c
target range had increased significantly from 25% to
above 45%. As published in the previous papers of this
supplement, the main finding of the SWEET analyses
of current status was the extreme heterogeneity of
pediatric diabetes care systems across the European
Union (EU); yet, at this stage of the project we cannot
assess whether (and to what extent) this heterogeneity
is reflected in the metabolic control or quality-of-life of
patients. Over the past 3 yr, multidisciplinary SWEET
Centers of Reference (CORs) have been created,
defining and providing appropriate diabetes care for
young people. However, there remains more work to
be done. Next to communicating about appropriate
care and treatment, the SWEET project identified the
need for a continuous monitoring system, which will
also provide a tool to import data to an online system
for data management (7). As such, a database was
created about Diabetes Care across Europe with the
purpose to monitor and reduce inequalities in care
between and within countries. Benchmarking between
centers will identify cost-efficient delivery of care,
leading to reduced inequalities, improved care and
health outcomes, and efficient use of resources. The
present paper reviews the process and the prerequisites
of becoming a COR and describes the initial data
collected. In conclusion, in addition to ongoing data
analysis with benchmarking on an international level,
the major advantages for implementing a system of
CORs and becoming a COR are fourfold:
• A common objective of targets and guidelines
• Recognition of expertise in treatment and education
• Political influence on a national and European level
• Implementation and dissemination of new appro-
aches and techniques
Methods
During the European project period seven SWEET
meetings were organized. All project partners includ-
ing the Steering Committee of International Society
for Pediatric and Adolescent Diabetes (ISPAD),
International Diabetes Federation (IDF), and Federa-
tion of European Nurses in Diabetes, an independent
Advisory Assessment Committee including a repre-
sentative of a parent’s organization and a medical
ethics specialist, corporate partners, and other key
stakeholders (e.g., pediatric diabetes research organi-
zations) were invited. The definition of a COR and the
outline of the process to become a COR have been the
product of these discussion based on the information
collected during project, which is outlined in the other
papers of this supplement. The process toward a COR
included the following steps: (i) application (ii) need
to submit electronic data annually (iii) nomination
for Collaborative Center (iv) need to meet criteria
during 3 yr (v) audit (vi) nomination for COR. The
requirements and criteria for a SWEET Collaborative
Center and SWEET COR are summarized in Table 1.
National and regional differences will make it
necessary that children will be treated in a system
of different levels of care. Depending on local
circumstances, not every European country will need
all the levels of care that are proposed within the
SWEET project; however, we suggest that at least one
COR with the best level of care should be established
in each country, although several countries will have
significantly more CORs. Within the SWEET project,
we distinguish between three levels of care:
• Level 1: Regular hospital/practice: care for its own
geographical area:
Particularly in sparsely populated areas primary
care physicians will play an important role to deliver
care on a local basis. Models for the collaboration
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Table 1. Summary of requirements for becoming a Center of Reference (COR)
Requirements for a SWEET Collaborative Center
Has an electronic health record with longitudinal data (minimum: age, diabetes duration, gender, diabetes type, and
hemoglobin A1c) of 150 patients with an age of ≤18 yr
Is involved in a quality circle with this data
Employs a pediatrician with diabetes expertise and a nurse with pediatric diabetes expertise
Knowledge and skills of a dietician, psychologist, and/or social worker are present
Follows the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines
Includes at least one ISPAD member
Fulfills national requirements for specialist education
Has out-patient diabetes services with confirmed in-patient access
Requirements for a SWEET COR
Member of SWEET e.V. – payment of membership fee
Need to submit data annually (usually every 6 months) to the central server (at least twice)
One-year no data transfer: ‘yellow card’
Two-year no data transfer: loss of present accreditation
Audit every 5 yr
Criteria of a SWEET COR – checked by peer review/audit
Sufficient activity and capacity to provide relevant services at a sustained level of quality
Capacity to provide expert advice, diagnosis, or confirmation of diagnosis, to produce or adhere to good practice guidelines,
and to implement outcome measures and quality control
Multidisciplinary approach with pediatric diabetes expertise
High level of expertise and experience, as documented through publications, grants, or honorific position, teaching and
training activities
Strong contribution to research
Involvement in epidemiological surveillance such as registries
Close links and collaboration with other national and international expert centers, and capacity to network
Close links and collaboration with patient associations where they exist
Appropriate arrangements for patient referrals from other European Union countries
Appropriate capacities for diagnosing, following up, and managing patients with evidence of good outcome where applicable
between these level 1 points of care with specialized
multidisciplinary teams have been developed, for
example, in the Federal State of Schleswig-Holstein
in Germany (8) or in its most extreme form with the
Outreach Clinics in Australia (9).
• Level 2: SWEET Collaborating Center:
The adherence of a large proportion or number of
patients is covering a geographical area that contains
a number of regular hospitals. This center would be
a prospective COR but may lack some characteristics
at the time. Collaboration within the SWEET project
with help of the SWEET toolbox will help to raise
the bar to eventually become a COR if it so desires.
It is mandatory as a SWEET Collaborating Center
to submit anonymous data on quality control to the
SWEET database.
• Level 3: SWEET COR:
Such a center would fulfill level 2 on addition to
all criteria outlined below and would be involved in
the development of ‘new state of the art’ treatment
strategies: research (applied and/or basic), education,
and should be leading and taking initiatives in national
programs (reimbursement, guidelines, and education),
linked with international collaborations on related
matters. In addition to a regular submission of data like
a SWEET Collaborating Center, a COR will undergo
peer review with an audit process described below.
Several workshops have outlined the definitions for
becoming a ‘Collaborating Center’ in order to even-
tually qualify to become a ‘COR’: in order to ensure
sufficient resources, the Center should treat at least
150 patients with an age of ≤18 yr. This minimum
patient number is justified below. The qualified multi-
disciplinary approach has to be guaranteed by having
a pediatrician with diabetes expertise and a nurse with
pediatric diabetes expertise. In addition, the presence of
knowledge and skilled dietitian, psychologist, and/or
social worker is recommended. To ensure links to
the International Scientific Community, at least one
ISPAD member has to be employed at the Center.
There is the need to have an electronic health record
with longitudinal data documentation on, at least,
the following: age, diabetes duration, gender, diabetes
type, and HbA1c. This is required as a basis for con-
tinuous process and outcome data evaluation. It is
required to participate in quality circle inclusive data
analysis and to follow the ISPAD guidelines (10). The
respective national curriculum for specialist education
needs to be fulfilled, and out-patient diabetes services
with confirmed in-patient access need to be established.
SWEET members felt that the same treatment philoso-
phy should be followed through the whole circle of care.
64 Pediatric Diabetes 2012: 13 (Suppl. 16): 62–75
Pediatric Centers of Reference
Fig. 1. Example certificate of a Center of Reference (COR). All CORs are approved by International Society for Pediatric and Adolescent
Diabetes (ISPAD) and International Diabetes Federation (IDF) Europe for a time period of 2 yr. Depending on sufficient submission of
longitudinal data, the certificates are renewed every year with a repeated audit process every 5 yr.
The accreditation is delivered by SWEET with
approval from ISPAD and IDF Europe. For those
Centers that have been approved as Collaborative
Centers for at least 1 yr they may be then recognized as
COR (Fig. 1). As the COR is based on sustained efforts
in for care of children and adolescents with diabetes,
1 yr was felt as minimum for establishing a continuum
of exchange between the new and established members
of SWEET. Each COR needs to submit data annually
(usually every 6 months) to the central server. This is
needed as incomplete data collection or patients ‘lost
to follow-up’ were considered as important factors in
evaluating process quality data. For the ongoing data
collection, it was proposed that 1-yr no data transfer
would result in a warning ‘yellow card’, whereas 2-yr
without data transfer would result in a loss of the
present accreditation. The electronic data review needs
to be checked by an auditing visit to each Center with
peer review every 5 yr. As a balance between cost and
effort of regular assessment vs. the risk of infrequent
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peer review, such a cycle was chosen as a consensus of
the original SWEET group and will be reevaluated on
a continuous basis.
Results
Initial data analysis of the centers from different
countries in Europe reporting their 2011 data showed
a high fill in rate of almost 100% (Fig. 2). The number
of patients treated varied significantly between the
centers. The mean age of the patients is dependent on if
the pediatric diabetes clinic is caring for young adults
as well, that is how, and at which age, the transition to
adult care is locally arranged. We can conclude that in
centers with about the same tradition of transferring
the patients at the age of 18 yr, the mean age of the
whole group is about the same in the different countries,
around 13 yr. There has been a trend during the latest
20 yr in Northern Europe to lower age at diagnosis
(11) but the majority of patients are teenagers. In some
centers, the follow-up age limit is extended to fulfill the
wishes and needs of patients beyond the 18–25-yr old
until they a reach more established treatment results.
As can be seen from Fig. 3, the amount of the different
health care professionals (HCPs) per patient largely
varies and does not simply reflect the time-consuming
efforts associated with insulin pump treatment. Also,
the admissions rate varies largely, which is assumed to
be related to local logistic and/or financial reasons.
The duration of diabetes in the treated patients tracks
in parallel as expected with the age of the patients and is
around 7 yr. As the data were uploaded retrospectively
as well as prospectively, a first glimpse at changes in
metabolic control within the center is possible (Fig. 4),
although potential bias regarding representativeness of
data and differential completeness of follow-up need
to be assessed further. Clearly, presently the data are
biased as the number of patients entered in a lot of
participating centers was not representative for the
whole center. The longitudinal changes of the average
HbA1c have already led to intense discussions between
the members of the SWEET group and will likely
lead to changes in local practices aiming at further
improvement of outcomes.
As much as transparency through data exchange and
a quality circle are the most important tools for quality
development, the SWEET group has introduced the
principle of frequent peer review by means of an
external audit process as additional tool in the process
of becoming a COR. A structured form was developed
to guide the peer review (Appendix). To sustain the
high level of care this external center visit needs to be
repeated every 5 yr. For the initial 12 centers approved
by ISPAD and IDF Europe, this audit was provided
by members from the original SWEET group. The
auditors needed to follow a structured interview and
personal center visit to check all aspects relevant for
COR application (Appendix). Within the structure
of the new legal entity SWEET e.V., it is planned
to develop an independent audit process of auditors
trained in the specific aspects relevant to pediatric
diabetology. Currently, the documents of the audit
and the COR application are reviewed by the boards
of ISPAD and IDF Europe after a recommendation
by the SWEET board.
Discussion
The present report summarizes the discussions on the
process of becoming a COR and the initial data col-
lected from the first 12 CORs. Through extensive struc-
tures in health care, it is indispensable to concentrate
diabetes relevant information and to gain more effi-
ciency in all aspects through a sophisticated networking
of the parties. The outcome of the interdisciplinary
care of the patients in medical practices, hospitals, and
ambulatory health care centers as well as the imple-
mentation of integrated utility supply contracts needs
evaluation. A reliable, computerized, on-line registry
for diabetes-related variables facilitates and admits
focus on indicators of quality and process in the daily
work at the local, out-patient clinic. The registry can
be used for comparison of data within the diabetes unit
but also as a tool for comparison and benchmarking
between different units in the country and between
countries.
In Sweden, there exists an operational national
registry of pediatric diabetes data since 2000 (SWE-
DIABKIDS). Since the web-based on-line registry was
introduced in January 2008 with unblinded results from
every clinic, there is an obvious trend toward better out-
come data in those clinics using the data actively (12).
The number of patients widely varied among CORs;
moreover, we could observe a significant bias toward
university hospitals and centers from countries with a
more advanced system of quality control. Clearly, the
participating SWEET clinics should not be regarded
as representative for the whole country but as a basis
to establish the criteria. Thus, the present evaluation
cannot determine the minimum effective size of a
center. Nevertheless, we observed within the project
that the centers in the lowest quartile are less likely
to have a qualified pediatric specialist nurse, an
educator, or a psychologist (Table 3 in reference 5).
Although we may assume that the responders of the
SWEET questionnaire are biased toward the more
active ISPAD members, the overall picture of centers
taking care of almost 30 000 diabetic patients cannot
be overlooked. In our opinion, one of the prerequisites
necessary for establishing any quality control system
is determining a minimum number of patients. This
‘critical mass’ of patients enables an allocation of
66 Pediatric Diabetes 2012: 13 (Suppl. 16): 62–75
Pediatric Centers of Reference
Fig. 2. Status of the resubmission of data of the initially approved Centers of Reference. Not all centers were able to submit electronic data
of 150 patients with an age of <19 yr at the due date (top panel). The boxes on the bars represent the total number of patients or the mean
age, diabetes duration, or hemoglobin A1c (HbA1c) at the different centers. The completeness of the data (in %) can be seen in the little box
beneath the average HbA1c. Bars are grouped according to mean, so not all individual center data are placed at the same position.
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Fig. 3. Heterogeneity in health care delivery: results of the audit process, total number of patients, and profile data and number of patients
served by different health care professionals (HCPs).
Fig. 4. Longitudinal changes in the hemoglobin A1c (HbA1c) as major outcome parameter of average metabolic control for children with
diabetes treated in the different Center of Reference over time.
adequate resources, ensures effective education, and
lets the personnel achieve proficiency by daily contacts
with the patients. This minimum number may depend
on the geographical, institutional, and organizational
issues specific to the individual countries.
The taskforce of the SWEET project has set the min-
imum number of patients for the SWEET collaborative
centers to 150. As can be seen in the previous paper
(5), many centers in Europe will be able to fulfill this
criterion. Nevertheless, the audit process revealed that
the exact allocation of resources differs considerably. It
can be expected that setting such a level will even help to
stimulate center growth and increase staffing quantity
and quality in many countries. Center size and internal
structure of the team influence the health care costs
largely. For example, the audit process confirmed that
admission rates differ largely between countries and
therefore this will have an impact on costs. An appro-
priate reimbursement on out-patient care and organi-
zation of care preventing unnecessary admission will
reduce costs. Expenditure for personnel is estimated
to be approximately 70–80% of total costs of an out-
patient clinic (excluding use of patient consumables).
The relationship of these two parameters can be seen
in Fig. 3. Despite all differences in attitudes, treatment
regimens, and admission rates, the figure suggests that
centers can be too small to be cost-effective. Therefore,
in some geographical areas, allowing centralization of
care may reduce costs. Also, the numbers of patients in
many clinics do not justify to specialize a fulltime and
focused effort or to have local colleagues with the same
focus. Centralization may thus facilitate expertise. The
cost savings may then be shifted to more upcoming
technologies to further improve the outcome, which is
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Fig. 5. Estimated relationship between the health care provider
(HCP) resources per year of treatment per patient. In these data, the
costs for additional personnel involved in hospital are not included.
The costs for a medical specialist are estimated as 2.5 times higher
compared to other HCP. The virtual equivalent cost of a non-
specialist team member is set as 1 for comparative purposes. Red
centers gave a hospital admission rate of more than 50% and the
orange have more than 10%, whereas others are lower (blue) or
unknown (white). Data are based on information collected during
the audit process.
of major importance for the long-term cost savings for
the treatment for complications. At the same time, the
complexity of these new technologies requires expertise
for which the changing structure of care is required.
Other diseases such as leukemia and cystic fibrosis have
already benefited from the changes in the structure
of care.
Diabetes is a chronic disease where a high quality
of care has a proven impact on the prognosis of the
individual patient in terms of life expectancy and
quality-of-life (13). It also has an obvious impact on
society in terms of medical costs, insurance expendi-
tures, and working capacity of the stricken patients
(14). A high quality of care is possible by prospective
measurement of the target achievement by the single
diabetes unit. The guidelines to follow should be based
on evidence, relying on solid data from a high number
of patients, who are treated according to a well-defined
policy and updated according to the results. The
SWEET group has decided as a next step to develop
SWEETONLINE to enable the patient to login for
access to his/her own patient portal and to fill in
forms on quality-of-life measurement. This is thought
to be a major step forward to a person-centered
care (15).
To sustain the achievements that have been
accomplished within the project 2007104: ‘SWEET’,
which has received funding from the EU in the
framework of the Public Health Programme, the
existing network has been transformed into a legal
entity, SWEET e.V., as a registered charity. The
leading role of the most important worldwide society
for pediatric diabetes, ISPAD, has been implemented in
the constitution to ensure that any development within
SWEET is closely linked to evidence-based medicine
and future developments in pediatric diabetes therapy.
SWEET e.V is now an independent legal entity,
headquartered for practical reasons in Hannover,
Germany. Its constitution was modeled according to a
template used by the European Alliance for Diabetes
Research (www.euradia.com). SWEET is closely linked
to ISPAD, with one of the three positions leading the
organization being appointed by the ISPAD executive.
According to its agreed statutes, SWEET e.V. is a non-
profit organization, aiming to support the creation of
CORs for pediatric diabetes. A member of SWEET
e.V. can be ‘any charity in the area of diabetes and
any company that is interested in the aims of SWEET
e.V.’ The prerequisite for becoming a member is to
send an application for membership addressed to
the Executive Committee of SWEET e.V. Priorities
of SWEET e.V. moving forward are to develop and
conduct education programs for health professionals,
to accredit dedicated health professionals, such as
pediatric diabetologists, to produce and/or accredit
education programs for patients and parents, and
to audit and approve CORs. Furthermore, SWEET
e.V. will organize meetings to discuss SWEET data to
exchange information and best practices at national
and international levels, to develop and improve
pediatric diabetes IT tools, and to collaborate with
relevant agencies and organizations. In the short term,
SWEET wishes to expand beyond the original SWEET
partners and countries.
In this next phase, SWEET seeks therefore to expand
the implementation of these reference centers so that all
European patients and HCPs have access to innovative
diabetes care and information. The most efficient and
rapid way to exchange information is by an eHealth
system through which young people can communicate
and interact with their treatment center by uploading
and downloading individual diabetes-related data. In
addition, such system will allow for joint studies and the
rapid exchange of information between major centers
for pediatric diabetology to adequately implement
advances in diabetes therapy.
Now that the first CORs have been created, it
is the time to expand the implementation of these
centers so that all European patients and HCPs have
access to innovative diabetes care and information.
SWEET seeks to develop and establish an eHealth
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system through which young people can interact with
their treatment center by uploading and downloading
individual data. We look for means so that data can
be imported to an online system for data management,
creating a database about diabetes care across Europe.
This system will allow for monitoring inequalities
in care and for benchmarking, leading to reduced
inequalities, improved health outcomes, and efficient
use of resources. As diabetes is one of the most
common chronic diseases in children, the continued
work within the SWEET project may serve as an
excellent reference model for children suffering from
any type of chronic disease.
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Appendix
Audit form for pediatric diabetes Centers of
Reference
Audit form for 
 Pediatric Diabetes Centers of Reference 
www.sweet-project.eu 
SWEET 
Date of clinic visit  











University affiliated  
Hospital based  
Non-profit institute  
Private clinic  
Outpatient clinic [  ] General facility also other patient groups   
Facility dedicated for diabetes][
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(1) Paediatric diabetologist, (2) Paediatric endocrinologist, (3) Paediatrician physician, (4) Fellow, (5) Resident 
peadiatric, (6) Nurse specialist, (7) Dietician, (8) Psychologist, (9) Social worker, (10) other  
(11)……………………..(12)……………………..
care providers






only    
Patient notes in
Paper based
dossier   
Patient Notes in
Electronic Health
Record   
ALL PERSONEL   
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PATIENTS Total type 1 type 2 MODY Other 
Number patients 
Age range 
Number of new patients in last 
year: 
Recent diagnosis 
Elsewhere / referal 
Upper age limit / transition 





MDI+sensor in last yr 
CSII 
CSII +sensor in last yr 
Avg HbA1c (%) 
% patients HbA1c<7.5 
Avg number of annual visits 
Avg number of annual additional 
contacts (phone, email, 
intercurrent out-patient visits 
Hospital admissions in last year:
- New diagnosis DM 
- DKA 
- Hypoglycemia 
- Total number 
Education
a-All education by team members 
or  
b-(in part) outsourced 
Number of specific group 
education sessions in last year 
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Average group numbers 
Number of specific educations 
sessions for minority groups in 
last year 
Number of general info meetings 
for patients / parents in last year 
Involvement in  diabetes camps  
Involved in patient organisations 
Involved in national health care 
discussions 
Giving lectures 
Authorships in scientific papers 
Participation in clinical trials 
PART II - OBSERVATIONS by visitor (Free txt)  
(inter) national guidelines present 
and in use:  
- which one  
- by whom     
- consistent use 
Protocols 
- present 
- in use 
- compliance 
Urgent patient calls - 24h service  
- who? 
Indicators used for quality control 
of total patient group 
- which  
- frequency of evaluation 
Quality of patients health record 
keeping 
IT facilities 
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Team member meetings about: 
- patient treatment 
- patient education strategies 
- improvement strategies 
- organization issues 
- attendance of team         




- responsibility for patient   
  outcome 
Education program of care 
providers  
- internal 
- external and  
- for which team members 
Participation and involvement 
according part 1 of questionnaire 
Attitudes toward improvement 
strategies 
Greatest impediment for 
improvement 
- reimbursement issues for    
  patients 
- clinical facilities 
- insurance issues 
- personnel  
- financial 
CONCLUDING 
Eligible as EU diabetes 
reference center   maybe :   yes   no
 Impressions, similarities,   
 differences 
Most inspiring experiences 
Most urgent suggestion for 
improvement 
Location, date       Signature 
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